Acne conglobata responding to buserelin, a gonadotrophin-releasing hormone analogue.
A 65-year-old man who had had acne conglabata since early adult life was treated with buserelin for advanced prostatic cancer. Within 1 month of starting therapy, the inflammatory acne had completely resolved and this coincided with remission of the carcinoma. Gonadotrophin-releasing hormone analogues may be useful in the treatment of resistant acne.
D000152:Acne Vulgaris / Q000188:drug therapy*; D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D002064:Buserelin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy
D002064:Buserelin